FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308058855> ?p ?o ?g. }

• W4308058855 endingPage "146" @default.
• W4308058855 startingPage "136" @default.
• W4308058855 abstract "Acute kidney injury (AKI) is the most common side effect of the anti-cancer drug cisplatin, and currently, no effective preventive measures are available in clinical practice. Oxidative stress and DNA damage mechanisms may be involved in cisplatin-induced AKI. In this study, we prepared Kolliphor HS15-based myricetin-loaded (HS15-Myr) nanomicelles and explored the mechanism of protection against cisplatin-induced AKI. In vitro results showed that the HS15-Myr nanomicelles enhanced the antioxidant activity of myricetin (Myr) and inhibited cisplatin-induced proliferation inhibition of HK-2 cells. Moreover, the HS15-Myr nanomicelles inhibited cisplatin-induced reactive oxygen species accumulation, mitochondrial membrane potential reduction, and DNA damage, which might be related to the inhibition of the cyclic GMP–AMP synthase (cGAS)─stimulating interferon gene (STING) signaling pathway. In vivo results in mice showed that the significant reductions in body weight and renal indices and the increased blood urea nitrogen and serum creatinine levels induced by cisplatin could be significantly reversed by pretreating with the HS15-Myr nanomicelles. Furthermore, nanomicelle pretreatment significantly altered the activities of antioxidant enzymes (e.g., GSH, MDA, and SOD) induced by cisplatin. In addition, cisplatin-induced inflammatory responses in mouse kidney tissue were found to be inhibited by pretreatment with HS15-Myr nanomicelles, such as IL-1β and TNF-α expression. The nanomicelles also significantly inhibited cisplatin-induced activation of the DNA damage-cGAS–STING pathway in kidney tissues. Together, our findings suggest that Myr-loaded nanomicelles are potential nephroprotective drugs." @default.
• W4308058855 created "2022-11-07" @default.
• W4308058855 creator A5025030643 @default.
• W4308058855 creator A5028384782 @default.
• W4308058855 creator A5037677450 @default.
• W4308058855 creator A5063013565 @default.
• W4308058855 creator A5063244036 @default.
• W4308058855 creator A5066990845 @default.
• W4308058855 creator A5078931811 @default.
• W4308058855 date "2022-11-03" @default.
• W4308058855 modified "2023-09-27" @default.
• W4308058855 title "Myricetin-Loaded Nanomicelles Protect against Cisplatin-Induced Acute Kidney Injury by Inhibiting the DNA Damage-cGAS–STING Signaling Pathway" @default.
• W4308058855 cites W1559117436 @default.
• W4308058855 cites W1975141618 @default.
• W4308058855 cites W1978210814 @default.
• W4308058855 cites W1987604182 @default.
• W4308058855 cites W2003703629 @default.
• W4308058855 cites W2042433863 @default.
• W4308058855 cites W2094156327 @default.
• W4308058855 cites W2165640222 @default.
• W4308058855 cites W2221792601 @default.
• W4308058855 cites W2425634544 @default.
• W4308058855 cites W2432819573 @default.
• W4308058855 cites W2467842911 @default.
• W4308058855 cites W2604619953 @default.
• W4308058855 cites W2753432471 @default.
• W4308058855 cites W2802480234 @default.
• W4308058855 cites W2891654049 @default.
• W4308058855 cites W2897219144 @default.
• W4308058855 cites W2901476092 @default.
• W4308058855 cites W2904544742 @default.
• W4308058855 cites W2912250863 @default.
• W4308058855 cites W2915645504 @default.
• W4308058855 cites W2936435806 @default.
• W4308058855 cites W2947913329 @default.
• W4308058855 cites W2973265448 @default.
• W4308058855 cites W3004780772 @default.
• W4308058855 cites W3013580342 @default.
• W4308058855 cites W3016405950 @default.
• W4308058855 cites W3088240852 @default.
• W4308058855 cites W3109207077 @default.
• W4308058855 cites W3111870857 @default.
• W4308058855 cites W3120882189 @default.
• W4308058855 cites W3121101545 @default.
• W4308058855 cites W3126592381 @default.
• W4308058855 cites W3142092103 @default.
• W4308058855 cites W3145334405 @default.
• W4308058855 cites W3192236714 @default.
• W4308058855 cites W3196598430 @default.
• W4308058855 cites W3200256151 @default.
• W4308058855 cites W3202313368 @default.
• W4308058855 cites W3207384251 @default.
• W4308058855 cites W4206420200 @default.
• W4308058855 doi "https://doi.org/10.1021/acs.molpharmaceut.2c00520" @default.
• W4308058855 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36326450" @default.
• W4308058855 hasPublicationYear "2022" @default.
• W4308058855 type Work @default.
• W4308058855 citedByCount "7" @default.
• W4308058855 countsByYear W43080588552023 @default.
• W4308058855 crossrefType "journal-article" @default.
• W4308058855 hasAuthorship W4308058855A5025030643 @default.
• W4308058855 hasAuthorship W4308058855A5028384782 @default.
• W4308058855 hasAuthorship W4308058855A5037677450 @default.
• W4308058855 hasAuthorship W4308058855A5063013565 @default.
• W4308058855 hasAuthorship W4308058855A5063244036 @default.
• W4308058855 hasAuthorship W4308058855A5066990845 @default.
• W4308058855 hasAuthorship W4308058855A5078931811 @default.
• W4308058855 hasConcept C104317684 @default.
• W4308058855 hasConcept C126322002 @default.
• W4308058855 hasConcept C141231307 @default.
• W4308058855 hasConcept C143425029 @default.
• W4308058855 hasConcept C185592680 @default.
• W4308058855 hasConcept C24389824 @default.
• W4308058855 hasConcept C2776151105 @default.
• W4308058855 hasConcept C2776694085 @default.
• W4308058855 hasConcept C2777810353 @default.
• W4308058855 hasConcept C2778004101 @default.
• W4308058855 hasConcept C2778173338 @default.
• W4308058855 hasConcept C2778239845 @default.
• W4308058855 hasConcept C2780091579 @default.
• W4308058855 hasConcept C2781263971 @default.
• W4308058855 hasConcept C48349386 @default.
• W4308058855 hasConcept C552990157 @default.
• W4308058855 hasConcept C55493867 @default.
• W4308058855 hasConcept C71924100 @default.
• W4308058855 hasConcept C86803240 @default.
• W4308058855 hasConcept C98274493 @default.
• W4308058855 hasConceptScore W4308058855C104317684 @default.
• W4308058855 hasConceptScore W4308058855C126322002 @default.
• W4308058855 hasConceptScore W4308058855C141231307 @default.
• W4308058855 hasConceptScore W4308058855C143425029 @default.
• W4308058855 hasConceptScore W4308058855C185592680 @default.
• W4308058855 hasConceptScore W4308058855C24389824 @default.
• W4308058855 hasConceptScore W4308058855C2776151105 @default.
• W4308058855 hasConceptScore W4308058855C2776694085 @default.
• W4308058855 hasConceptScore W4308058855C2777810353 @default.
• W4308058855 hasConceptScore W4308058855C2778004101 @default.
• W4308058855 hasConceptScore W4308058855C2778173338 @default.

• next